key articles
EAU-JUA joint session discusses hypertension as a risk factor for storage symptoms
Wednesday, 18 March, 2007- Hypertension is a risk factor for storage symptoms, but not voiding system in patients with various urological conditions, according to a report presented at the 24th Annual EAU Congress by Dr. O....
By Evgenia Starkova
Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A dose finding study
Friday, 3 October 2008 - Phosphodiesterase type 5 inhibitors are widely used to treat erectile dysfunction. Preliminary data have suggested phosphodiesterase type 5 inhibitor efficacy in men with lower urinary tract symptoms...
Authors: Roehrborn et al.
Endoscopic excision of an eroding calcified mesh sling, 10 years after primary surgery
Wednesday, 1 October 2008 - Management of urethral erosion typically entails two options: sling incision (in the early postoperative period) or excision of the suburethral part of the sling (urethrolysis). Wadie (2008) described...
Authors: Wadie et al.
Role of lower urinary tract symptoms and quality of life in deciding prostate-specific antigen testing and prostate biopsy
Saturday, 6 September 2008 - Avery et al. (2008) investigated whether men's self-reported health-related quality of life and lower urinary tract symptoms (LUTS) are associated with acceptance of prostate-specific antigen (PSA)...
Authors: Avery et al.
Destruction of lower urinary tract by ketamine abuse: a new syndrome?
Tuesday, 19 August 2008 - Chu et al. (2008) reported the clinical spectrum seen in young abusers of street-ketamine (regular recreational abusers of street-ketamine, for its hallucinogenic effects) in Hong Kong, presenting with...
Authors: Chu et al.
Lower urinary tract symptoms and risk of prostate cancer
Sunday, 17 August 2008 - Screening for early prostate cancer is frequently employed in the routine management of men with lower urinary tract symptoms (LUTS), but the evidence-base linking LUTS with prostate cancer is...
Authors: Martin et al.
Nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms
Friday, 1 August 2008 - Nitric oxide (NO) pathway is a potential pharmacological target to treat male lower urinary tract symptoms (LUTS). In the prostate transition zone, a dense nitrinergic innervation shows the fibromuscular...
Authors: Kedia et al.
Ultrasound-estimated bladder weight predicts surgery risk for benign prostatic hyperplasia
Wednesday, 30 July 2008 - Although invasive and expensive, the pressure-flow study is known as the reference standard for the diagnosis of bladder outlet obstruction. Akino et al. (2008) investigated the usefulness of...
Authors: Akino et al.
Transurethral prostate resection in patients with elevated prostate-specific antigen, minor lower urinary tract symptoms, and proven bladder outlet obstruction
Tuesday, 29 July 2008 - It is complex to decide a treatment strategy for patients with minor lower urinary tract symptoms (LUTS), elevated prostate-specific antigen (PSA) levels, unsuspicious digital rectal examination (DRE)...
Authors:
Tolterodine extended release with or without tamsulosin for lower urinary tract symptoms
Wednesday, 23 July 2008 - Some men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB) symptoms may benefit from antimuscarinic therapy, with or without an alpha-adrenergic antagonist. Roehrborn et al....
Authors: Roehrborn et al.
